S-200 (Sopharmia)

N/A

Report date: 2025/06/11 10:47:57
NME

Base Information

Drug NameS-200 (Sopharmia)
Drug Alias NameS-201.1S202.2S-200S-104S-201
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSopharmia Inc
China Registration ClassN/A

Develop Information

Active CompaniesSopharmia Inc
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A